Resources for Sponsors Expanding Immuno-oncology Pipeline Assets

Steven Anderson PhD, Chief Scientific Officer

Covance immuno-oncology drug development timeline
Contact Us
icon-info-sheet
left-img-info-sheet-biopharma-solutions

Maximizing asset value with solutions designed for biopharma

icon-immuno-oncology-expertise
left-img-capabilities

Discover our expertise in immuno-oncology drug development

icon-webinar-video
Marketplace video
icon-case-study
Case study: Flexibility for a successful partnership

Rapidly establishing relevant models for preclinical oncology success

icon-white-paper
left-img-case-study-addressing-immunotherapy

Evidence-based approaches to address challenges in immuno-oncology

icon-white-paper
left-img-white-paper-complementary-diagnostics

Highlights of personalized medicine in immuno-oncology

icon-case-study
Case study: End-to-end drug and diagnostic development

Support in immuno-oncology from preclinical design to approved product launch